Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA

Long noncoding RNAs (lncRNAs) are a subclass of noncoding RNAs composed of more than 200 nucleotides without the ability to encode functional proteins. Given their involvement in critical cellular processes such as gene expression regulation, transcription, and translation, lncRNAs play a significan...

Full description

Bibliographic Details
Main Authors: Seyedeh Tayebeh Ahmadpour, Charlotte Orre, Priscila Silvana Bertevello, Delphine Mirebeau-Prunier, Jean-François Dumas, Valérie Desquiret-Dumas
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/21/15897
_version_ 1797631773150019584
author Seyedeh Tayebeh Ahmadpour
Charlotte Orre
Priscila Silvana Bertevello
Delphine Mirebeau-Prunier
Jean-François Dumas
Valérie Desquiret-Dumas
author_facet Seyedeh Tayebeh Ahmadpour
Charlotte Orre
Priscila Silvana Bertevello
Delphine Mirebeau-Prunier
Jean-François Dumas
Valérie Desquiret-Dumas
author_sort Seyedeh Tayebeh Ahmadpour
collection DOAJ
description Long noncoding RNAs (lncRNAs) are a subclass of noncoding RNAs composed of more than 200 nucleotides without the ability to encode functional proteins. Given their involvement in critical cellular processes such as gene expression regulation, transcription, and translation, lncRNAs play a significant role in organism homeostasis. Breast cancer (BC) is the second most common cancer worldwide and evidence has shown a relationship between aberrant lncRNA expression and BC development. One of the main obstacles in BC control is multidrug chemoresistance, which is associated with the deregulation of multiple mechanisms such as efflux transporter activity, mitochondrial metabolism reprogramming, and epigenetic regulation as well as apoptosis and autophagy. Studies have shown the involvement of a large number of lncRNAs in the regulation of such pathways. However, the underlying mechanism is not clearly elucidated. In this review, we present the principal mechanisms associated with BC chemoresistance that can be directly or indirectly regulated by lncRNA, highlighting the importance of lncRNA in controlling BC chemoresistance. Understanding these mechanisms in deep detail may interest the clinical outcome of BC patients and could be used as therapeutic targets to overcome BC therapy resistance.
first_indexed 2024-03-11T11:27:05Z
format Article
id doaj.art-2a560549079c4f2ebf89f5c8a68ba260
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T11:27:05Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2a560549079c4f2ebf89f5c8a68ba2602023-11-10T15:05:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-11-0124211589710.3390/ijms242115897Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNASeyedeh Tayebeh Ahmadpour0Charlotte Orre1Priscila Silvana Bertevello2Delphine Mirebeau-Prunier3Jean-François Dumas4Valérie Desquiret-Dumas5Nutrition, Croissance et Cancer, Inserm, UMR1069, Université de Tours, 37032 Tours, FranceInserm U1083, UMR CNRS 6214, Angers University, 49933 Angers, FranceNutrition, Croissance et Cancer, Inserm, UMR1069, Université de Tours, 37032 Tours, FranceInserm U1083, UMR CNRS 6214, Angers University, 49933 Angers, FranceNutrition, Croissance et Cancer, Inserm, UMR1069, Université de Tours, 37032 Tours, FranceInserm U1083, UMR CNRS 6214, Angers University, 49933 Angers, FranceLong noncoding RNAs (lncRNAs) are a subclass of noncoding RNAs composed of more than 200 nucleotides without the ability to encode functional proteins. Given their involvement in critical cellular processes such as gene expression regulation, transcription, and translation, lncRNAs play a significant role in organism homeostasis. Breast cancer (BC) is the second most common cancer worldwide and evidence has shown a relationship between aberrant lncRNA expression and BC development. One of the main obstacles in BC control is multidrug chemoresistance, which is associated with the deregulation of multiple mechanisms such as efflux transporter activity, mitochondrial metabolism reprogramming, and epigenetic regulation as well as apoptosis and autophagy. Studies have shown the involvement of a large number of lncRNAs in the regulation of such pathways. However, the underlying mechanism is not clearly elucidated. In this review, we present the principal mechanisms associated with BC chemoresistance that can be directly or indirectly regulated by lncRNA, highlighting the importance of lncRNA in controlling BC chemoresistance. Understanding these mechanisms in deep detail may interest the clinical outcome of BC patients and could be used as therapeutic targets to overcome BC therapy resistance.https://www.mdpi.com/1422-0067/24/21/15897breast cancerchemoresistancelong noncoding RNAmetabolism
spellingShingle Seyedeh Tayebeh Ahmadpour
Charlotte Orre
Priscila Silvana Bertevello
Delphine Mirebeau-Prunier
Jean-François Dumas
Valérie Desquiret-Dumas
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
International Journal of Molecular Sciences
breast cancer
chemoresistance
long noncoding RNA
metabolism
title Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
title_full Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
title_fullStr Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
title_full_unstemmed Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
title_short Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
title_sort breast cancer chemoresistance insights into the regulatory role of lncrna
topic breast cancer
chemoresistance
long noncoding RNA
metabolism
url https://www.mdpi.com/1422-0067/24/21/15897
work_keys_str_mv AT seyedehtayebehahmadpour breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna
AT charlotteorre breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna
AT priscilasilvanabertevello breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna
AT delphinemirebeauprunier breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna
AT jeanfrancoisdumas breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna
AT valeriedesquiretdumas breastcancerchemoresistanceinsightsintotheregulatoryroleoflncrna